SCHEMBL30179404

SCHEMBL30179404

CCOC(=O)N1CCCN(C2CCC3(CC2)C(=O)Nc2cc(F)ccc23)CC1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPK1 P28482 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HRH3 Q9Y5N1 4/20 0.44
MAPK14 Q16539 1/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 1/20 0.41
ALOX12 P18054 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.40
OPRM1 P35372 2/20 0.40
OPRK1 P41145 2/20 0.40
OPRL1 P41146 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20066051 1.00 ALDH1A1 (0.45) ALDH1A1KDM4EMAPK1MEN1KMT2A
SCHEMBL30179220 0.93 ALDH1A1 (0.45) ALDH1A1KDM4EMAPK1MEN1KMT2A
SCHEMBL20066050 0.93 ALDH1A1 (0.45) ALDH1A1KDM4EMAPK1MEN1KMT2A
SCHEMBL30179202 0.92 SMN1; SMN2 (0.49) ALDH1A1KDM4EMAPK1MEN1KMT2A
SCHEMBL20066048 0.92 SMN1; SMN2 (0.49) ALDH1A1KDM4EMAPK1MEN1KMT2A
SCHEMBL30179251 0.88 ALDH1A1 (0.47) ALDH1A1KDM4EMAPK1HRH3MAPK14
SCHEMBL20066054 0.88 ALDH1A1 (0.47) ALDH1A1KDM4EMAPK1HRH3MAPK14
SCHEMBL30179395 0.87 OPRM1 (0.46) MAPK1MEN1KMT2AHRH3GAA
SCHEMBL20066046 0.87 OPRM1 (0.46) MAPK1MEN1KMT2AHRH3GAA
SCHEMBL20066055 0.87 MGLL (0.43) MAPK1HRH3MAPK14GAAALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109996792-B Heterocyclic compounds having activity as modulators of muscarinic M1 and/or M4 receptors in the treatment of CNS diseases and pain 赫普泰雅治疗有限公司 2023-02-17 CN disclosed